Dr. Lowrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1992
Tufts Medical CenterResidency, Internal Medicine, 1985 - 1987
Boston University School of MedicineClass of 1985
Certifications & Licensure
NH State Medical License 1993 - 2023
ME State Medical License 2020 - 2021
MD State Medical License 1988 - 1994- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia Start of enrollment: 1996 Sep 01
- Protocol to Obtain Blood Samples for Leukemia Research Start of enrollment: 2009 Apr 01
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes Start of enrollment: 1996 May 01
- Join now to see all
Publications & Presentations
PubMed
- 128 citationsHypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentJie Deng, Jiannan Li, Aurelien Sarde, J. Louise Lines, Yu-Chi Lee
Cancer Immunology Research. 2019-07-01 - 115 citationsRegulation of MCL1 through a Serum Response Factor/Elk-1-mediated Mechanism Links Expression of a Viability-promoting Member of the BCL2 Family to the Induction of Hem...Karen J. Townsend, Ping Zhou, Liping Qian, Christine K. Bieszczad, Christopher H. Lowrey
The Journal of Biological Chemistry. 1999-01-15 - 95 citationsUBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemiaSutisak Kitareewan, Ian Pitha-Rowe, David Sekula, Christopher H. Lowrey, Michael J. Nemeth
Proceedings of the National Academy of Sciences of the United States of America. 2002-03-19
Press Mentions
MD-PhD Student Cynthia Hahn Named 2015-16 Syvertsen FellowDecember 8th, 2015
Grant Support
- Mechanisms Underlying The Pharmacologic Induction Of Fetal HemoglobinNational Heart, Lung, And Blood Institute2009–2010
- Promoter Chromatin Structure In Fetal Globin SilencingNational Heart, Lung, And Blood Institute2003–2006
- Regulation Of Beta-Globin Locus Chromatin StructureNational Heart, Lung, And Blood Institute1995–2006
- Regulation Of Beta Globin Locus Chromatin StructureNational Heart, Lung, And Blood Institute1999–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
